作者: A.W.L. Joss , M.M. Davidson , D.O. Ho-Yen , A. Ludbrook
DOI: 10.1016/S0033-3506(03)00067-2
关键词:
摘要: This paper analyses likely Lyme disease costs incurred by patients tested in the authors' laboratory over an 18 month period, based on patient histories and test results relating to 2110 samples submitted from laboratories serving 59% of Scottish population. Cost analysis takes account direct consultation, tests, antibiotic treatment management any sequelae, as well indirect loss healthy time through illness. Standard for each element are derived published information, proportions applied category estimated studies described elsewhere literature. Of sample, 295 had evidence early 31 late symptoms. Based these figures, total annual cost disease, when projected whole Scotland, is be significant at 331,000 Pounds (range 47,000-615,000 Pounds). The range inevitably wide because it was not possible document complete clinical individual patients. In addition, some sequelae will require more than 1 year, also identified that could justifiably included all other who negative disease. These data raise question whether there sufficient focus prevention best this